| Patient | Zora Neale Hurston |
|---|---|
| Date of birth | 1891-01-07 |
| Identifiers | MRN HR-ML040-SYN-TD; SSN (made up) 000-40-6213 |
| Document date | 2026-11-01 |
| Author | Lorraine Abernathy-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care for morning headaches, breathlessness on exertion and ankle swelling, with very high blood pressure: examination, ECG, laboratory tests, 24-hour ambulatory blood pressure monitoring, a two-drug combination, food and medicine-cost screening, and stroke warning signs. Concerns: She wants to keep teaching, writing and gardening, and to get her breath back; She cannot afford expensive medicines or extra trips, and food runs short at the end of the month; She wants her own account of her symptoms to be believed and every choice explained. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet every morning | One tablet every morning | Oral route | 1958-03-09 | active | S |
| Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) every morning | One-half tablet every morning | Oral route | 1958-03-09 | active | S |
| Dapagliflozin 10 mg oral tablet, one tablet daily; pause on days of vomiting, diarrhea or not eating or drinking | One tablet daily, with sick-day rules | Oral route | 1958-03-23 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1958-03-23 | active | S |
| Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) daily | One-half tablet daily | Oral route | 1958-04-06 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Twelve-lead electrocardiogram: sinus rhythm at 80 per minute, left ventricular hypertrophy by voltage criteria with repolarization changes, no atrial fibrillation, no Q waves | 1958-03-09 to 1958-03-09 | completed | S |
| 24-hour ambulatory blood pressure monitoring, fitted at the visit and returned the next morning, before the first doses of blood pressure medicine | 1958-03-09 to 1958-03-09 | completed | S |
| Transthoracic echocardiography: ejection fraction 62%, concentric left ventricular hypertrophy (septum 13 mm, posterior wall 12 mm), grade II diastolic dysfunction with average E/e' 15, left atrial volume index 38 mL/m2, tricuspid regurgitation velocity 2.8 m/s, no significant valve disease, no pericardial effusion | 1958-03-23 to 1958-03-23 | completed | S |
| Twelve-lead electrocardiogram at the sick visit: sinus rhythm at 96 per minute, left ventricular hypertrophy unchanged from intake, no arrhythmia | 1958-05-18 to 1958-05-18 | completed | S |
| Advance care planning conversation, about 20 minutes, with her consent | 1958-09-14 to 1958-09-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1958-03-23 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1958-09-14 | High-dose influenza vaccine, this season | completed | S |
| 1958-09-14 | Respiratory syncytial virus vaccine, single dose | completed | S |
| 1958-09-14 | COVID-19 vaccine, mRNA, this season | completed | S |
| 1958-10-19 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
| 1958-10-19 | Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died in 1904, when the patient was 13; cause not recorded in the cited source | D (CLM-0004) |
| Concern | Status | Evidence |
|---|---|---|
| She wants to keep teaching, writing and gardening, and to get her breath back | active | S |
| She cannot afford expensive medicines or extra trips, and food runs short at the end of the month | active | S |
| She wants her own account of her symptoms to be believed and every choice explained | active | S |
Most recent measures: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 480 on 1958-03-09; Sodium [Moles/volume] in Serum or Plasma 139 on 1958-10-19; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1958-10-19; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 1958-10-19; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M 68 on 1958-10-19; Glucose [Mass/volume] in Serum or Plasma 96 on 1958-10-19; Magnesium [Mass/volume] in Serum or Plasma 2 on 1958-10-19; Hemoglobin [Mass/volume] in Blood 12.4 on 1958-03-09; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 1958-03-09; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 1958-03-09; Cholesterol [Mass/volume] in Serum or Plasma 152 on 1958-06-01; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 76 on 1958-06-01; Cholesterol in HDL [Mass/volume] in Serum or Plasma 53 on 1958-06-01; Triglyceride [Mass/volume] in Serum or Plasma 115 on 1958-06-01; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19 on 1958-06-01; Albumin/Creatinine [Mass Ratio] in Urine 22 on 1958-03-09; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1958-09-14; Left ventricular Ejection fraction 62 on 1958-03-23; Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area 38 on 1958-03-23; Heart valve E velocity/Annulus E wave by US 15 on 1958-03-23; Overall summary score [KCCQ-12] 78 on 1958-10-19; Total score [Mini-Cog] 5 on 1958-09-14; Total score [AUDIT-C] 1 on 1958-09-14 [S]
Strengths and supports: Strengths and supports: raised in Eatonville, an all-Black town she calls home; a lifelong collector of stories; describes a wide circle of friends, students and neighbors, and a sense of humor she relies on [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Very high blood pressure at intake (178/104 and 174/102 mmHg) with morning headaches for two months, without signs of a hypertensive emergency; not previously diagnosed; ambulatory monitoring to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting problem, resolved when ambulatory monitoring and the echocardiogram established the diagnosis at the second visit. Not a claim about her real blood pressure. |
| Breathlessness on exertion for three months (walking to the school, carrying groceries) with mild ankle swelling by evening; cause to be determined | resolved | confirmed | R06.09 | S — Synthetic presenting problem, resolved into the heart failure diagnosis at the second visit. |
| Hypertensive heart disease with heart failure: stage 2 hypertension confirmed by 24-hour ambulatory monitoring (mean 158/96 mmHg, non-dipping at night), with concentric left ventricular hypertrophy on ECG and echocardiogram; synthetic modern episode linked to the hypertensive heart disease recorded as her cause of death | active | confirmed | I11.0 | S — Synthetic modern diagnosis made at the second visit; the 1960 cause of death remains D. |
| Heart failure with preserved ejection fraction (ejection fraction 62%), NYHA class II, with grade II diastolic dysfunction and an enlarged left atrium | active | confirmed | I50.32 | S — Synthetic modern diagnosis confirmed by echocardiogram and cardiology at the second visit. |
| Food insecurity: food runs short at the end of most months (Hunger Vital Sign positive) | active | confirmed | Z59.41 | S — Synthetic social need anchored to her documented poverty. |
| Low and irregular income from substitute teaching and newspaper writing, with Original Medicare but no drug coverage; medicine costs a barrier | active | confirmed | Z59.6 | S — Synthetic social need anchored to her documented low income in the 1950s. |
| Orthostatic hypotension with lightheadedness on standing, from volume depletion in early summer heat on a diuretic, spironolactone and an SGLT2 inhibitor; no fall or faint; resolved after two days off those medicines and more fluid | resolved | confirmed | I95.1 | S — Synthetic intercurrent problem at an unscheduled visit; it follows from the treatment plan and the climate and does not echo a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1958-03-09 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 480 | pg/mL | Below 125 pg/mL makes heart failure unlikely outside the hospital | High | S |
| 1958-03-09 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1958-03-09 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1958-03-09 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1958-03-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1958-03-09 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 1958-03-09 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1958-03-09 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 1958-03-09 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1958-03-09 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 1958-03-09 | Cholesterol [Mass/volume] in Serum or Plasma | 212 | mg/dL | <=199 mg/dL | High | S |
| 1958-03-09 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 132 | mg/dL | <=99 mg/dL | High | S |
| 1958-03-09 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 54 | mg/dL | >=50 mg/dL | Normal | S |
| 1958-03-09 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 1958-03-09 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-35 U/L | Normal | S |
| 1958-03-09 | Albumin/Creatinine [Mass Ratio] in Urine | 22 | mg/g | Below 30 mg/g is normal | Normal | S |
| 1958-03-09 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1958-03-23 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1958-03-23 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1958-03-23 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1958-03-23 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M | 67 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1958-03-23 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 1958-03-23 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1958-03-23 | Left ventricular Ejection fraction | 62 | % | 50-70% | Normal | S |
| 1958-03-23 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 38 | mL/m2 | <=34 mL/m² | High | S |
| 1958-03-23 | Heart valve E velocity/Annulus E wave by US | 15 | {ratio} | <=14 | High | S |
| 1958-03-23 | Overall summary score [KCCQ-12] | 54 | {score} | S | ||
| 1958-04-06 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1958-04-06 | Potassium [Moles/volume] in Serum or Plasma | 3.4 | mmol/L | 3.5-5.1 mmol/L | Low | S |
| 1958-04-06 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1958-04-06 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M | 63 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1958-04-06 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1958-04-06 | Magnesium [Mass/volume] in Serum or Plasma | 1.8 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1958-06-01 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1958-06-01 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1958-06-01 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1958-06-01 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M | 65 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1958-06-01 | Glucose [Mass/volume] in Serum or Plasma | 95 | mg/dL | 70-99 mg/dL | Normal | S |
| 1958-06-01 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1958-06-01 | Cholesterol [Mass/volume] in Serum or Plasma | 152 | mg/dL | <=199 mg/dL | Normal | S |
| 1958-06-01 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 76 | mg/dL | <=99 mg/dL | Normal | S |
| 1958-06-01 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 53 | mg/dL | >=50 mg/dL | Normal | S |
| 1958-06-01 | Triglyceride [Mass/volume] in Serum or Plasma | 115 | mg/dL | <=149 mg/dL | Normal | S |
| 1958-06-01 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 | U/L | 7-35 U/L | Normal | S |
| 1958-06-01 | Overall summary score [KCCQ-12] | 72 | {score} | S | ||
| 1958-05-18 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 1958-05-18 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1958-05-18 | Creatinine [Mass/volume] in Serum or Plasma | 1.1 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 1958-05-18 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M | 55 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 1958-05-18 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1958-09-14 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1958-10-19 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1958-10-19 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1958-10-19 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1958-10-19 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M | 68 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1958-10-19 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 1958-10-19 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 1958-10-19 | Overall summary score [KCCQ-12] | 78 | {score} | S | ||
| 1958-09-14 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 1958-09-14 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1958-03-09 | Body height | 165 | cm | S |
| 1958-03-09 | Body weight | 84.2 | kg | S |
| 1958-03-09 | Body mass index (BMI) [Ratio] | 30.9 | kg/m2 | S |
| 1958-03-09 | Systolic blood pressure | 176 | mm[Hg] | S |
| 1958-03-09 | Diastolic blood pressure | 103 | mm[Hg] | S |
| 1958-03-09 | Heart rate | 82 | /min | S |
| 1958-03-09 | Respiratory rate | 18 | /min | S |
| 1958-03-09 | Body temperature | 36.7 | Cel | S |
| 1958-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 1958-03-23 | Body height | 165 | cm | S |
| 1958-03-23 | Body weight | 83.4 | kg | S |
| 1958-03-23 | Body mass index (BMI) [Ratio] | 30.6 | kg/m2 | S |
| 1958-03-23 | Systolic blood pressure | 150 | mm[Hg] | S |
| 1958-03-23 | Diastolic blood pressure | 90 | mm[Hg] | S |
| 1958-03-23 | Heart rate | 78 | /min | S |
| 1958-03-23 | Respiratory rate | 16 | /min | S |
| 1958-03-23 | Body temperature | 36.6 | Cel | S |
| 1958-03-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1958-04-06 | Body height | 165 | cm | S |
| 1958-04-06 | Body weight | 82.6 | kg | S |
| 1958-04-06 | Body mass index (BMI) [Ratio] | 30.3 | kg/m2 | S |
| 1958-04-06 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1958-04-06 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1958-04-06 | Heart rate | 76 | /min | S |
| 1958-04-06 | Respiratory rate | 16 | /min | S |
| 1958-04-06 | Body temperature | 36.7 | Cel | S |
| 1958-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1958-06-01 | Body height | 165 | cm | S |
| 1958-06-01 | Body weight | 81.8 | kg | S |
| 1958-06-01 | Body mass index (BMI) [Ratio] | 30 | kg/m2 | S |
| 1958-06-01 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1958-06-01 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1958-06-01 | Heart rate | 72 | /min | S |
| 1958-06-01 | Respiratory rate | 16 | /min | S |
| 1958-06-01 | Body temperature | 36.6 | Cel | S |
| 1958-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1958-10-19 | Body height | 165 | cm | S |
| 1958-10-19 | Body weight | 81.2 | kg | S |
| 1958-10-19 | Body mass index (BMI) [Ratio] | 29.8 | kg/m2 | S |
| 1958-10-19 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1958-10-19 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1958-10-19 | Heart rate | 70 | /min | S |
| 1958-10-19 | Respiratory rate | 16 | /min | S |
| 1958-10-19 | Body temperature | 36.5 | Cel | S |
| 1958-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1958-05-18 | Body height | 165 | cm | S |
| 1958-05-18 | Body weight | 80.6 | kg | S |
| 1958-05-18 | Body mass index (BMI) [Ratio] | 29.6 | kg/m2 | S |
| 1958-05-18 | Systolic blood pressure | 112 | mm[Hg] | S |
| 1958-05-18 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1958-05-18 | Heart rate | 94 | /min | S |
| 1958-05-18 | Respiratory rate | 16 | /min | S |
| 1958-05-18 | Body temperature | 36.9 | Cel | S |
| 1958-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1958-09-14 | Body height | 165 | cm | S |
| 1958-09-14 | Body weight | 81.6 | kg | S |
| 1958-09-14 | Body mass index (BMI) [Ratio] | 30 | kg/m2 | S |
| 1958-09-14 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1958-09-14 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1958-09-14 | Heart rate | 70 | /min | S |
| 1958-09-14 | Respiratory rate | 16 | /min | S |
| 1958-09-14 | Body temperature | 36.6 | Cel | S |
| 1958-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1958-03-09 | Establishing care for morning headaches, breathlessness on exertion and ankle swelling, with very high blood pressure: examination, ECG, laboratory tests, 24-hour ambulatory blood pressure monitoring, a two-drug combination, food and medicine-cost screening, and stroke warning signs | finished | S |
| 1958-03-23 | Two-week review: ambulatory blood pressure result, echocardiogram, metabolic panel, cardiology consultation the same day, and the diagnosis | finished | S |
| 1958-04-06 | Two-week review after dapagliflozin: metabolic panel, blood pressure and potassium, and benefits applications | finished | S |
| 1958-06-01 | Eight-week review: blood pressure at home and in the clinic, potassium and kidney function, lipids, KCCQ-12 and drug coverage | finished | S |
| 1958-10-19 | Seven-month review: blood pressure, heart failure status, metabolic panel, stroke prevention and plans for the year | finished | S |
| 1958-05-18 | Same-day sick visit for lightheadedness on standing in the heat | finished | S |
| 1958-09-14 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Respectful, shared decision-making: take her history as given, explain each test and medicine with its reasons and alternatives, write the plan down, and check costs with her before prescribing | completed | GL-AHA-HTN-2025 | S |
| Cardiology consultation on the day of the two-week visit, with the echocardiogram, to confirm the cause of breathlessness, look for hypertensive heart disease and HFpEF and their mimics, and advise on treatment | completed | GL-HF-2022, GL-HFPEF-2023, GL-CMID-2026 | S |
| Confirm the diagnosis with 24-hour ambulatory blood pressure monitoring today, before the first dose; then home readings twice daily with a validated upper-arm monitor and a large cuff lent by the clinic | completed | GL-AHA-HTN-2025, GL-CMID-2026 | S |
| Start a two-drug combination for stage 2 hypertension: chlorthalidone 12.5 mg and amlodipine 5 mg every morning, from the morning after the ambulatory monitor is removed, as low-cost generics; target below 130/80 mmHg; less salt, using foods she already eats | completed | GL-AHA-HTN-2025, GL-CMID-2026 | S |
| Baseline tests: ECG, NT-proBNP, metabolic panel and magnesium, hemoglobin, TSH, hemoglobin A1c, lipids, ALT and urine albumin-to-creatinine ratio; echocardiogram because of raised NT-proBNP, breathlessness and suspected left ventricular hypertrophy | completed | GL-AHA-HTN-2025, GL-HF-2022, GL-CMID-2026 | S |
| Stroke and emergency warning signs: BE FAST (balance, eyes, face, arm, speech, time to call 911), and call 911 for chest pain, severe headache with confusion or vision loss, or breathlessness at rest | completed | GL-CDC-BEFAST, GL-AHA-HTN-2025 | S |
| Costs and coverage, with the clinic's community health worker: a SHINE counselor for Extra Help and the Medicare Savings Program; generic medicines in 90-day fills; patient assistance for any brand-only medicine until coverage begins | completed | GL-EXTRAHELP, GL-MSP, GL-SHINE | S |
| Food: the Hunger Vital Sign at intake; help applying for SNAP through ACCESS Florida; the food pantry list | completed | GL-HVS, GL-SNAP, GL-FL-ACCESS | S |
| Heart failure treatment: dapagliflozin 10 mg daily with sick-day rules; daily weights with a written plan; metabolic panel one to two weeks after each start or dose change, then every three to six months; KCCQ-12 every three to six months | completed | GL-HF-2022, GL-HFPEF-2023, GL-CMID-2026 | S |
| Atorvastatin 20 mg daily for primary prevention, with a lipid panel at four to twelve weeks | completed | GL-AHA-HTN-2025, GL-CMID-2026 | S |
| Add spironolactone 12.5 mg daily for blood pressure above target and low potassium on chlorthalidone; potassium and creatinine one to two weeks later | completed | GL-HF-2022, GL-AHA-HTN-2025 | S |
| Laboratory checks on the day of clinic visits where possible, and rides through the county's transportation program for people without a car when a separate trip is needed | completed | GL-CMID-2026 | S |
| Heat plan for the Florida summer: fans and cooling places, water through the day, sick-day rules for chlorthalidone, spironolactone and dapagliflozin, and the energy assistance program's cooling help | completed | GL-HF-2022, GL-LIHEAP | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Blood pressure below 130/80 mmHg in the clinic and at home within six months | 1958-06-01 | completed | 126/76 in the clinic; home average 124/74 | S |
| Breathlessness only on heavy exertion and a KCCQ-12 score at least 15 points higher within six months | 1958-10-19 | completed | KCCQ-12 54 to 78; NYHA class I to II; ankles no longer swell | S |
| Every medicine affordable: generic 90-day fills, patient assistance until drug coverage begins, Extra Help and the Medicare Savings Program | 1958-06-01 | completed | Extra Help and the Medicare Savings Program approved; enrolled in a drug plan; dapagliflozin by patient assistance until then | S |
| Enough food through the month | 1958-06-01 | completed | SNAP approved and the food pantry at her church; food lasts the month | S |
| Know the BE FAST signs of stroke and call 911 at once if any appear | 1958-04-06 | completed | She teaches back the signs and keeps the card by the telephone | S |